OrthoPediatrics (KIDS) Competitors $18.10 +0.01 (+0.06%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$18.10 0.00 (0.00%) As of 10/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KIDS vs. ENOV, CDRE, NVCR, CNMD, KMTS, PLSE, BLFS, ESTA, SSII, and MDXGShould you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include Enovis (ENOV), Cadre (CDRE), NovoCure (NVCR), CONMED (CNMD), Kestra Medical Technologies (KMTS), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Establishment Labs (ESTA), SS Innovations International (SSII), and MiMedx Group (MDXG). These companies are all part of the "medical equipment" industry. OrthoPediatrics vs. Its Competitors Enovis Cadre NovoCure CONMED Kestra Medical Technologies Pulse Biosciences BioLife Solutions Establishment Labs SS Innovations International MiMedx Group Enovis (NYSE:ENOV) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation. Is ENOV or KIDS more profitable? OrthoPediatrics has a net margin of -18.92% compared to Enovis' net margin of -37.80%. Enovis' return on equity of 6.78% beat OrthoPediatrics' return on equity.Company Net Margins Return on Equity Return on Assets Enovis-37.80% 6.78% 3.73% OrthoPediatrics -18.92%-6.36%-4.69% Do institutionals & insiders believe in ENOV or KIDS? 98.5% of Enovis shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 2.7% of Enovis shares are owned by insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, ENOV or KIDS? Enovis has a beta of 1.69, meaning that its share price is 69% more volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Which has better earnings & valuation, ENOV or KIDS? OrthoPediatrics has lower revenue, but higher earnings than Enovis. OrthoPediatrics is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnovis$2.11B0.86-$825.49M-$14.25-2.23OrthoPediatrics$204.73M2.22-$37.82M-$1.79-10.11 Does the media favor ENOV or KIDS? In the previous week, Enovis had 7 more articles in the media than OrthoPediatrics. MarketBeat recorded 8 mentions for Enovis and 1 mentions for OrthoPediatrics. Enovis' average media sentiment score of 1.11 beat OrthoPediatrics' score of 1.02 indicating that Enovis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enovis 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer ENOV or KIDS? Enovis currently has a consensus price target of $51.00, indicating a potential upside of 60.63%. OrthoPediatrics has a consensus price target of $34.14, indicating a potential upside of 88.63%. Given OrthoPediatrics' higher possible upside, analysts clearly believe OrthoPediatrics is more favorable than Enovis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enovis 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71OrthoPediatrics 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 SummaryEnovis beats OrthoPediatrics on 9 of the 16 factors compared between the two stocks. Get OrthoPediatrics News Delivered to You Automatically Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KIDS vs. The Competition Export to ExcelMetricOrthoPediatricsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$453.58M$6.99B$6.09B$10.54BDividend YieldN/A1.16%5.69%4.71%P/E Ratio-10.1127.6685.3527.60Price / Sales2.22195.36539.78202.41Price / CashN/A21.7337.9261.55Price / Book1.245.4513.016.76Net Income-$37.82M$178.04M$3.30B$275.88M7 Day Performance0.95%4.21%4.34%2.81%1 Month Performance-11.66%12.27%9.49%9.24%1 Year Performance-26.00%34.25%84.83%35.42% OrthoPediatrics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KIDSOrthoPediatrics4.6299 of 5 stars$18.10+0.1%$34.14+88.6%-26.1%$453.58M$204.73M-10.11200Positive NewsAnalyst ForecastENOVEnovis3.754 of 5 stars$30.19+0.7%$51.00+68.9%-18.2%$1.71B$2.11B-2.127,367News CoverageAnalyst ForecastCDRECadre2.1731 of 5 stars$36.06-0.8%$31.50-12.6%-1.3%$1.48B$567.56M38.362,284News CoverageAnalyst ForecastNVCRNovoCure4.1445 of 5 stars$12.92+0.2%$28.79+122.8%-2.1%$1.44B$605.22M-8.281,488Positive NewsAnalyst ForecastCNMDCONMED4.6281 of 5 stars$45.64-0.8%$59.80+31.0%-27.2%$1.42B$1.31B12.933,900Analyst ForecastKMTSKestra Medical Technologies1.1152 of 5 stars$23.41-3.8%$27.33+16.8%N/A$1.25B$66.40M0.00300Analyst ForecastPLSEPulse Biosciences3.193 of 5 stars$17.80+0.2%$22.00+23.6%+26.3%$1.20B$700K-16.95140Analyst ForecastBLFSBioLife Solutions2.1074 of 5 stars$24.52-0.7%$31.29+27.6%+15.2%$1.18B$93.47M-204.32440Positive NewsAnalyst ForecastESTAEstablishment Labs2.7699 of 5 stars$41.37+5.8%$56.50+36.6%-5.6%$1.13B$166.02M-13.561,018News CoveragePositive NewsAnalyst ForecastSSIISS Innovations InternationalN/A$5.65+1.6%N/AN/A$1.08B$20.65M0.004Analyst ForecastMDXGMiMedx Group3.3822 of 5 stars$6.93-0.1%$12.00+73.2%+26.8%$1.03B$348.88M33.00870Positive NewsAnalyst Forecast Related Companies and Tools Related Companies ENOV Competitors CDRE Competitors NVCR Competitors CNMD Competitors KMTS Competitors PLSE Competitors BLFS Competitors ESTA Competitors SSII Competitors MDXG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KIDS) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OrthoPediatrics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OrthoPediatrics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
